Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Rahul Jandial, MD, PhD

City of Hope Comprehensive Cancer Treatment Center in California

Disrupting metabolic adaptations in breast-to-brain metastases

Rinath Jeslesohn, MD

Dana Farber Cancer Institute

Presented by the Philadelphia METAvivor Gala in memory of Kerry O’Riordan McAdam and in honor of Jacqueline Beck

Integrative multi-omics and immune profiling with machine learning for optimization of treatment in metastatic hormone receptor positive breast cancer

Dennis Jones, PhD

Boston University

Presented by Metavivor Facebook Fundraisers

Targeting breast cancer plasticity and immunosuppression in metastatic lymph nodes

CHERYL JORCYK, PhD

Boise State University

High Impact Therapeutic for the Elimination of Breast Cancer Metastasis to Bone

Vadim Jucaud, PhD

Terasaki Institute for Biomedical Innovation

Presented by the Moore/Smith Family in memory of Carol Smith, wife, mother, friend and advocate

Microengineered approach to develop personalized monoclonal antibodies for metastatic breast cancer treatment

Sheheryar Kabraji, BMBCh

Dana-Farber Cancer Institute

Presented by 2019 METAbash

Targeting drug-resistant quiescent cancer cells in breast cancer brain metastases

ADRIANA KAHN, MD

Yale University

Presented by Jackson #LightUpMBC Glow Walk, in loving memory of Mary Cero and Alicia Sheckard

Sacituzumab Tirumotecan to Treat Patients with Brain Metastases from Triple-Negative Breast Cancer – BERLIN Trial

David Kamson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital

Presented by Jacqueline Vranicar – In memory of Lindsay Block

A Translational Observational Biorepository and Management Study In Patients with Leptomeningeal Metastasis: The BIOLEPT Study

Yibin Kang, PhD

Princeton University

Presented by The Fraternal Order of Eagles

Preventing Regulatory T cell Induction to Enhance Immunity Against Breast Cancer Metastases

YIBIN KANG, PhD

Princeton University

Development of a Humanized Mouse Model of Breast Cancer Liver Metastasis

YIBIN KANG, PhD

Princeton University

Sensitizing Bone Metastasis to Chemotherapy and Radiotherapy by Targeting Jagged1-Mediated Tumor-Stromal Interactions

Bethany Kerr, PhD

Wake Forest School of Medicine

Presented in Honor of Beth Fairchild and Her Service to Metavivor Research and Support

Profiling combinatorial treatment response in early and late bone metastatic breast cancer